BRUSSELS - U.S. drugmaker Pfizer gained European Union antitrust approval on Tuesday for its proposed $15 billion acquisition of U.S. rival Hospira after pledging to sell some drugs to allay competition concerns.
NEW YORK - Mayor Bill de Blasio said on Tuesday a historic outbreak of Legionnaires' disease that killed seven New Yorkers has triggered an effort to mandate city-wide inspections and cleanings of air conditioning cooling towers. | Video
(Reuters Health) - A decades old Medicare rule requiring a three-day hospital stay before patients can transfer to skilled nursing facilities may needlessly prolong hospitalizations, a study suggests.
NEW YORK - A diet rich in green leafy vegetables, beans, berries, whole grains and wine can help to slow normal brain aging and cognitive decline, researchers said on Tuesday.
- Hospitals that can afford it should take steps beyond those recommended by the manufacturer to clean and disinfect a type of device at the center of a recent superbug outbreak in the United States, health regulators said on Tuesday.
- Closer coordination between healthcare facilities and public health departments could save 37,000 U.S. lives over five years by preventing infections from antibiotic-resistant germs and from a nasty intestinal bug called C. difficile, according to a government report released on Tuesday.
WASHINGTON - Republican legislation to cut off federal funding for Planned Parenthood failed to gather enough support in the U.S. Senate on Monday, halting at least for now moves to punish the women's health group for its role in gathering fetal tissue from abortions for medical research.
(Reuters Health) - Some veterans may experience a sharper decline in symptoms of post-traumatic stress disorder (PTSD) with mindfulness-based stress reduction therapy than with other forms of group treatment, a study suggests.
(Reuters Health) - Violence remains a problem for many Americans despite substantial progress since the 1980s and 1990s, according to the Centers for Disease Control and Prevention.
- The U.S. Food and Drug Administration said it will update the label of Novartis AG's multiple sclerosis drug, Gilenya, after cases of serious brain infections were linked with its use.